Surgery

Dr. Joseph Cullen’s project, “Ascorbate-induced radiosensitization in pancreatic cancer,” has recently been awarded grant funding by the National Institutes of Health (NIH)

Cullen, Joseph

Dr. Joseph Cullen’s project, “Ascorbate-induced radiosensitization in pancreatic cancer,” has recently been awarded grant funding by the National Institutes of Health (NIH). The project is being funded through the “U” grant mechanism to reflect Dr. Cullen’s close collaboration with NIH program staff—specifically, Dr. Mark Levine, who serves as Chief of the Molecular and Clinical Nutrition Section of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Dr. Cullen’s project continues his promising investigations into using pharmacological intravenous ascorbate (i.e., ascorbic acid, vitamin C), as an adjuvant to radio-therapy, to treat pancreas cancer.

Dr. Cullen has also received an Oberley Seed Grant from the Holden Comprehensive Cancer Center, as well as additional funding through the Veterans' Affairs (VA) Merit Program.